2012
DOI: 10.1182/blood-2011-10-383083
|View full text |Cite
|
Sign up to set email alerts
|

C/EBPα and DEK coordinately regulate myeloid differentiation

Abstract: The transcription factor C/EBP␣ is a critical mediator of myeloid differentiation and is often functionally impaired in acute myeloid leukemia. Recent studies have suggested that oncogenic FLT3 activity disrupts wild-type C/EBP␣ function via phosphorylation on serine 21 (S21). Despite the apparent role of pS21 as a negative regulator of C/EBP␣ transcription activity, the mechanism by which phosphorylation tips the balance between transcriptionally competent and inhibited forms remains unresolved. In the presen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
43
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 43 publications
(44 citation statements)
references
References 49 publications
(69 reference statements)
1
43
0
Order By: Relevance
“…logical contexts (12,13,(31)(32)(33). Continued development in mass spectrometry acquisition methods (34 -37) may provide further improvements in the performance of iTRAQbased quantitative studies.…”
Section: Discussionmentioning
confidence: 99%
“…logical contexts (12,13,(31)(32)(33). Continued development in mass spectrometry acquisition methods (34 -37) may provide further improvements in the performance of iTRAQbased quantitative studies.…”
Section: Discussionmentioning
confidence: 99%
“…However, and of most relevance to the present studies, DEK interacts with AP-2␣ and stimulates transactivation (88) and also interacts with C/EBP␣, an important coactivator of myeloid target genes (89), where DEK knockdown disrupts granulocyte differentiation. DEK, accompanied by AP-2␣ recruitment, becomes enriched at a site proximal to the CD21 promoter upon its transcriptional activation in B lymphocytes (90).…”
Section: Discussionmentioning
confidence: 99%
“…However, molecular studies of DEK oncogenicity have mostly focused on roles of DEK in interphase cells, where DEK is constitutively bound to chromatin, and functions in transcription, replication and DNA repair. 18,31,36,[53][54][55][56][57] In this study we investigated the regulation of DEK in mitosis and found that endogenous DEK is removed from chromatin in early prophase and re-associates with chromatin in telophase as outlined in Figure 8A. Importantly, DEK over-expression leads to its aberrant retention on chromatin throughout mitosis (Fig.…”
Section: Discussionmentioning
confidence: 99%